Results 171 to 180 of about 760,353 (358)
339 Screening on- and off-target CAR-T cytotoxicity in solid tumors using patient-derived tumoroids [PDF]
Chris Yankaskas, Jenny Xiaoyu Yang, Maryam Mafreshi, Garrett Wong, Vivek Chandra, Erik Ensberg, V. Henry, Julia Braun, Colin Paul, Brittany Balhouse, Jason Sharp, Matt Dallas, David Kuninger, Erik Willems +13 moreopenalex +1 more sourceSupplementary Figure 3 from A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors
, 2023 Xiaojun Liu, Raghuveer Ranganathan, Shuguang Jiang, Chongyun Fang, Jing Sun, Soyeon Kim, Kheng Newick, Albert Lo, Carl H. June, Yangbing Zhao, Edmund K. Moon +10 moreopenalex +1 more sourceSupplementary Figure from First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors [PDF]
, 2023 Tae Won Kim, Howard A. Burris, Maria J. de Miguel, Michael J. Pishvaian, Yung‐Jue Bang, Michael S. Gordon, Ahmad Awada, D. Ross Camidge, F. Stephen Hodi, Grant A. McArthur, Wilson H. Miller, Andrés Cervantes, Laura Q.M. Chow, Alexander M. Lesokhin, Annemie Rutten, Mario Sznol, Deepali Rishipathak, Shang‐Chiung Chen, Eric Stefanich, Tony Pourmohamad, Maria Inêz Padula Anderson, Jeong Kim, Mahrukh Huseni, Ina Rhee, Lillian L. Siu +24 moreopenalex +1 more sourceCCR Translation for the Article from Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
, 2023 Jedd D. Wolchok, Axel Hoos, Steven O’Day, Jeffrey S. Weber, Omid Hamid, Célèste Lebbé, Michele Maio, Michael Binder, Oliver Bohnsack, Geoffrey Nichol, Rachel Humphrey, F. Stephen Hodi +11 moreopenalex +1 more sourceSupplementary Data from First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors [PDF]
, 2023 Timothy A. Yap, David S.P. Tan, Angelika Terbuch, Reece Caldwell, Christina Guo, Boon Cher Goh, Valerie Heong, Noor R. Md. Haris, Saira Bashir, Yvette Drew, David S. Hong, Funda Meric‐Bernstam, Gary Wilkinson, Joseph Hreiki, Antje M. Wengner, Friedhelm Bladt, Andreas Schlicker, Matthias Ludwig, Yinghui Zhou, Li Liu, Sonal Bordia, Ruth Plummer, Eleni Lagkadinou, Johann S. de Bono +23 moreopenalex +1 more sourceSubstrate Stress Relaxation Regulates Cell‐Mediated Assembly of Extracellular Matrix
Advanced Functional Materials, EarlyView.Silicone‐based viscoelastic substrates with tunable stress relaxation reveal how matrix mechanics regulates cellular mechanosensing and cell‐mediated matrix remodelling in the stiff regime. High stress relaxation promotes assembly of fibronectin fibril‐like structures, increased nuclear localization of YAP and formation of β1 integrin‐enriched ...Jonah L. Voigt, Jens Timmer, Elisabetta Ada Cavalcanti‐Adam +2 morewiley +1 more sourceEpidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy [PDF]
, 2008 Abderrahim Fandi, AP Meert, AS Merseburger, D Veale, DA Eberhard, David H. Johnson, DC Spaulding, DJ Slamon, DS Salomon, DW Bell, F Cappuzzo, F Cappuzzo, FA Shepherd, FR Hirsch, G Giaccone, Giuseppe Giaccone, International Conference on Harmonisation, J Brabender, J Gawrychowski, JG Paez, JP Kallio, JR Woodburn, Judith S. Ochs, L Bingle, M Volm, M-S Tsao, Mette Janas, N Thatcher, R Sordella, Renee B. Iacona, RI Nicholson, Roy S. Herbst, RS Herbst, RS Herbst, SJ Pocock, TJ Lynch, U Gatzemeier, Y Nakayama, Y Ohsaki +38 morecore +1 more sourceSupplemental Tables 1-4 from A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors
, 2023 David C. Smith, Peter D. Eisenberg, Georgy M. Manikhas, Rashmi Chugh, Matthew A. Gubens, Robert Stagg, Ann M. Kapoun, Lu Xu, Jakob Dupont, Branimir I. Šikić +9 moreopenalex +1 more source
